Revenue: The sum of all revenue fields included for a company's operating activities.
Ensysce Biosciences, Inc. (ENSC) had Revenue of $5.21M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$5.21M |
$-7.99M |
|
-- |
|
$5.21M |
|
$11.94M |
|
$-6.73M |
|
$-1.26M |
|
$-7.99M |
|
$-7.99M |
|
$-7.99M |
|
$-7.99M |
|
$-7.99M |
|
$-7.99M |
|
$-6.73M |
|
$-5.53M |
|
0.70M |
|
0.70M |
|
$-11.45 |
|
$-11.45 |
|
| Balance Sheet Financials | |
$5.34M |
|
-- |
|
$0.25M |
|
$5.60M |
|
$2.21M |
|
-- |
|
$0.01M |
|
$2.22M |
|
$3.38M |
|
$3.38M |
|
$3.38M |
|
1.36M |
|
| Cash Flow Statement Financials | |
$-7.50M |
|
-- |
|
$9.88M |
|
$1.12M |
|
$3.50M |
|
$2.38M |
|
$0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.42 |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
100.00% |
|
-129.18% |
|
-129.18% |
|
-106.20% |
|
-153.30% |
|
-153.30% |
|
$-7.50M |
|
-- |
|
-- |
|
-- |
|
0.93 |
|
-- |
|
41.98 |
|
8.70 |
|
-236.31% |
|
-236.31% |
|
-142.70% |
|
-236.31% |
|
$2.49 |
|
$-10.75 |
|
$-10.75 |
|